Internal Medicine, Pulmonary Disease · New Orleans, LA
NPI
1346650652
Since 2014
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1901 Perdido St Ste 3205
New Orleans, LA, 70112
Phone (504) 568-2903
Groups this clinician bills Medicare through
Medicare paid, 2024
$33K
295 services
Medicare patients, 2024
106
Average age 68
Drug cost, 2024
$4.7M
809 prescriptions
Company payments, 2025
$385
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amita Krishnan was code 99291 (critical care e&m), 122 times for 49 patients. In total Amita Krishnan billed 295 services in 28 codes, and Medicare paid $33K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-01-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99291 Critical Care E&M | Facility | 122 | 49 | $164.94 | $20K |
| 99215 Office E&M - Established | Facility | 34 | 23 | $107.93 | $3,670 |
| 99292 Critical Care E&M | Facility | 24 | 13 | $84.15 | $2,020 |
| 99214 Office E&M - Established | Facility | 19 | 15 | $72.13 | $1,371 |
By year: 2022 $35K for 368 services; 2023 $22K for 223 services; 2024 $33K for 295 services.
Medicare prescription drug claims, 2024
In 2024, the drug Amita Krishnan prescribed most often to Medicare patients was Opsumit (Macitentan), with 110 prescriptions and refills. In total Amita Krishnan wrote 809 Medicare prescriptions that cost $4.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Opsumit Macitentan | 110 | 110 | 13 | $1.4M |
| Mycophenolate Mofetil Generic | 67 | 152 | 28 | $15K |
| Ofev Nintedanib Esylate | 55 | 55 | Under 11 | $735K |
| Tyvaso Dpi Treprostinil | 42 | 42 | Under 11 | $997K |
| Azelastine Hcl Generic | 40 | 89 | 17 | $836 |
| Prednisone Generic | 40 | 85 | 14 | $134 |
| Furosemide Generic | 39 | 105 | 21 | $161 |
| Tadalafil Generic | 35 | 35 | Under 11 | $9,585 |
| Adempas Riociguat | 34 | 34 | Under 11 | $494K |
| Uptravi Selexipag | 29 | 29 | Under 11 | $724K |
| Fluticasone Propionate Generic | 19 | 28 | Under 11 | $297 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 18 | 18 | 11 | $321 |
| Methotrexate Methotrexate Sodium | 16 | 43 | Under 11 | $532 |
| Sildenafil Citrate Generic | 16 | 34 | Under 11 | $1,019 |
| Winrevair Sotatercept-Csrk | 15 | 15 | Under 11 | $213K |
Brand drugs: - claims; generic drugs: 450 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amita Krishnan $385 ($385 in general payments such as food, travel and fees) from 5 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $117.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.